| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,102,800 | 2,107,700 | 2,374,700 | 2,203,200 | | Cost of Revenue | 1,193,300 | 1,196,700 | 1,218,600 | 1,187,500 | | | Gross Profit | 909,500 | 911,000 | 1,156,100 | 1,015,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 492,700 | 577,400 | 520,400 | 573,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 416,800 | 333,600 | 635,700 | 442,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 161,600 | 30,900 | (4,100) | 38,800 | | Earnings Before Interest And Taxes | 450,500 | 364,500 | 631,600 | 481,400 | | Interest Expense | 3,200 | 3,500 | 2,400 | 8,200 | | Income Before Tax | 447,300 | 361,000 | 629,200 | 473,200 | | Income Tax Expense | 163,200 | 13,800 | 226,500 | 172,900 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 284,100 | 347,200 | 402,700 | 300,300 | | | Non-recurring Events | | Discontinued Operations |
-
| 5,400 |
-
| 100 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 284,100 | 352,600 | 402,700 | 300,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $284,100 | $352,600 | $402,700 | $300,400 |
|
0.52% Nasdaq 
Income Statement
